222 related articles for article (PubMed ID: 36980569)
1. Optical Genome Mapping for Cytogenetic Diagnostics in AML.
Nilius-Eliliwi V; Gerding WM; Schroers R; Nguyen HP; Vangala DB
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980569
[TBL] [Abstract][Full Text] [Related]
2. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients.
Gerding WM; Tembrink M; Nilius-Eliliwi V; Mika T; Dimopoulos F; Ladigan-Badura S; Eckhardt M; Pohl M; Wünnenberg M; Farshi P; Reimer P; Schroers R; Nguyen HP; Vangala DB
Int J Cancer; 2022 Jun; 150(12):1998-2011. PubMed ID: 35064925
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA.
Coccaro N; Anelli L; Zagaria A; Tarantini F; Cumbo C; Tota G; Minervini CF; Minervini A; Conserva MR; Redavid I; Parciante E; Macchia MG; Specchia G; Musto P; Albano F
Diagnostics (Basel); 2023 May; 13(11):. PubMed ID: 37296693
[TBL] [Abstract][Full Text] [Related]
4. Optical Genome Mapping as an Alternative to FISH-Based Cytogenetic Assessment in Chronic Lymphocytic Leukemia.
Valkama A; Vorimo S; Kumpula TA; Räsänen H; Savolainen ER; Pylkäs K; Mantere T
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831635
[TBL] [Abstract][Full Text] [Related]
5. Optical Genome Mapping as a Tool to Unveil New Molecular Findings in Hematological Patients with Complex Chromosomal Rearrangements.
Coccaro N; Zagaria A; Anelli L; Tarantini F; Tota G; Conserva MR; Cumbo C; Parciante E; Redavid I; Ingravallo G; Minervini CF; Minervini A; Specchia G; Musto P; Albano F
Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137002
[TBL] [Abstract][Full Text] [Related]
6. Optical Genome Mapping in Routine Cytogenetic Diagnosis of Acute Leukemia.
Soler G; Ouedraogo ZG; Goumy C; Lebecque B; Aspas Requena G; Ravinet A; Kanold J; Véronèse L; Tchirkov A
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046792
[TBL] [Abstract][Full Text] [Related]
7. Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping.
Neveling K; Mantere T; Vermeulen S; Oorsprong M; van Beek R; Kater-Baats E; Pauper M; van der Zande G; Smeets D; Weghuis DO; Stevens-Kroef MJPL; Hoischen A
Am J Hum Genet; 2021 Aug; 108(8):1423-1435. PubMed ID: 34237281
[TBL] [Abstract][Full Text] [Related]
8. Optical genome mapping in acute myeloid leukemia: a multicenter evaluation.
Levy B; Baughn LB; Akkari Y; Chartrand S; LaBarge B; Claxton D; Lennon PA; Cujar C; Kolhe R; Kroeger K; Pitel B; Sahajpal N; Sathanoori M; Vlad G; Zhang L; Fang M; Kanagal-Shamanna R; Broach JR
Blood Adv; 2023 Apr; 7(7):1297-1307. PubMed ID: 36417763
[TBL] [Abstract][Full Text] [Related]
9. Novel
Tembrink M; Gerding WM; Wieczorek S; Mika T; Schroers R; Nguyen HP; Vangala DB; Nilius-Eliliwi V
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296904
[TBL] [Abstract][Full Text] [Related]
10. Optical Genome Mapping as a Diagnostic Tool in Pediatric Acute Myeloid Leukemia.
Suttorp J; Lühmann JL; Behrens YL; Göhring G; Steinemann D; Reinhardt D; Neuhoff NV; Schneider M
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565187
[TBL] [Abstract][Full Text] [Related]
11. Genomic Characterization of Partial Tandem Duplication Involving the
Seto A; Downs G; King O; Salehi-Rad S; Baptista A; Chin K; Grenier S; Nwachukwu B; Tierens A; Minden MD; Smith AC; Capo-Chichi JM
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730645
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping.
Díaz-González Á; Mora E; Avetisyan G; Furió S; De la Puerta R; Gil JV; Liquori A; Villamón E; García-Hernández C; Santiago M; García-Ruiz C; Llop M; Ferrer-Lores B; Barragán E; García-Palomares S; Mayordomo E; Luna I; Vicente A; Cordón L; Senent L; Álvarez-Larrán A; Cervera J; De la Rubia J; Hernández-Boluda JC; Such E
Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37297002
[TBL] [Abstract][Full Text] [Related]
13. Analytic Validation of Optical Genome Mapping in Hematological Malignancies.
Pang AWC; Kosco K; Sahajpal NS; Sridhar A; Hauenstein J; Clifford B; Estabrook J; Chitsazan AD; Sahoo T; Iqbal A; Kolhe R; Raca G; Hastie AR; Chaubey A
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137484
[TBL] [Abstract][Full Text] [Related]
14. Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.
Lestringant V; Duployez N; Penther D; Luquet I; Derrieux C; Lutun A; Preudhomme C; West M; Ouled-Haddou H; Devoldere C; Marolleau JP; Garçon L; Jedraszak G; Ferret Y
Genes Chromosomes Cancer; 2021 Oct; 60(10):657-667. PubMed ID: 33982372
[TBL] [Abstract][Full Text] [Related]
15. Optical Genome Mapping for Comprehensive Assessment of Chromosomal Aberrations and Discovery of New Fusion Genes in Pediatric B-Acute Lymphoblastic Leukemia.
Gao H; Xu H; Wang C; Cui L; Huang X; Li W; Yue Z; Tian S; Zhao X; Xue T; Xing T; Li J; Wang Y; Zhang R; Li Z; Wang T
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612032
[TBL] [Abstract][Full Text] [Related]
16. Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping.
Rack K; De Bie J; Ameye G; Gielen O; Demeyer S; Cools J; De Keersmaecker K; Vermeesch JR; Maertens J; Segers H; Michaux L; Dewaele B
Am J Hematol; 2022 May; 97(5):548-561. PubMed ID: 35119131
[TBL] [Abstract][Full Text] [Related]
17. Optical Genome Mapping: A Revolutionary Tool for "Next Generation Cytogenomics Analysis" with a Broad Range of Diagnostic Applications in Human Diseases.
Garcia-Heras J
J Assoc Genet Technol; 2021; 47(4):191-200. PubMed ID: 34897113
[TBL] [Abstract][Full Text] [Related]
18. Broad genomic workup including optical genome mapping uncovers a
Nilius-Eliliwi V; Tembrink M; Gerding WM; Lubieniecki KP; Lubieniecka JM; Kankel S; Liehr T; Mika T; Dimopoulos F; Döhner K; Schroers R; Nguyen HHP; Vangala DB
Front Oncol; 2022; 12():959243. PubMed ID: 36158701
[TBL] [Abstract][Full Text] [Related]
19. Use of Optical Genome Mapping to Detect Structural Variants in Neuroblastoma.
Barford RG; Whittle E; Weir L; Fong FC; Goodman A; Hartley HE; Allinson LM; Tweddle DA
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958407
[TBL] [Abstract][Full Text] [Related]
20. Optical Genome Mapping Reveals the Complex Genetic Landscape of Myeloma.
Giguère A; Raymond-Bouchard I; Collin V; Claveau JS; Hébert J; LeBlanc R
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]